Delfi Diagnostics

Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients.…


Founded
2019
Headcount
168
Open roles
6
Last raised
Series B · $225M

SECTION I · THE BRIEF

Inside Delfi Diagnostics

Brief #65955Updated 18 NOV 2025BALTIMOREMENLO VENTURESSERIES B
Employbl Dossier

Delfi Diagnostics

Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the…

Founded
2019
Headcount
168
Open roles
6
Last raised
Series B · $225M
Section II — RestrictedMembers only
  • Engineering interview process at Delfi Diagnostics
  • Tech stack & infrastructure choices
  • Culture & day-to-day work style
  • Why join now vs. 6 months from now
  • Hiring focus & open headcount by team
  • Comp philosophy and band context

7-day free trial · $25/mo · cancel anytime


LEADERSHIP

Founders & key people

Victor VelculescuVictor Velculescu
Alessandro Leal
Nicholas DracopoliNicholas Dracopoli
Robert Scharpf

OPEN ROLES

Hiring at Delfi Diagnostics

Current Job Listings

Listing 0 of 6 job openings

    FUNDING

    Capital raised

    Total Amount Raised: $330,500,000

    Delfi Diagnostics' Investors

    Delfi Diagnostics Funding Rounds

    • Series B

      $225,000,000

    • Series B

      $225,000,000

      Series B Investors

      DFJ Growth
      Samsara BioCapital
      Eli Lilly and Company
      AV8 Ventures
      Point72
      Menlo Ventures
      Illumina Ventures
      Open Field Capital
      Windham Venture Partners
      T. Rowe Price
      Rock Springs Capital
      OrbiMed Advisors
      Point Field Partners
      Foresite Capital
      Cowen Healthcare Investments
      Brown Advisory
      OUP (Osage University Partners)
      Northpond Ventures
      PTX Capital
      Initiate Ventures
    • Series A

      $100,000,000

    • Series A

      $100,000,000

      Series A Investors

      OrbiMed Advisors
      AV8 Ventures
      Windham Venture Partners
      Rock Springs Capital
      Menlo Ventures
      Samsara BioCapital
      Northpond Ventures
      T. Rowe Price
      OUP (Osage University Partners)
      Cowen Healthcare Investments
      Foresite Capital
      Illumina Ventures
    • Seed

      $5,500,000

    • Seed

      $5,500,000

      Seed Investors

      Menlo Ventures
      Illumina Ventures
      AV8 Ventures
      Windham Venture Partners
      Samsara BioCapital
    Funding info provided by Diffbot.

    TAGS

    Categorized in

    Company Collections

    These are collections Delfi Diagnostics is a part of. Click on the collection name to view similar companies.

    Delfi Diagnostics' Investors


    LOCATIONS

    Where they work

    Delfi Diagnostics Headquarters Location

    1812 Ashland Avenue, Baltimore, MD, 21205

    Loading map…